KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EBT (2016 - 2025)

Historic EBT for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $279.2 million.

  • Zimmer Biomet Holdings' EBT rose 2123.32% to $279.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 99.8%. This contributed to the annual value of $1.0 billion for FY2024, which is 287.64% down from last year.
  • According to the latest figures from Q3 2025, Zimmer Biomet Holdings' EBT is $279.2 million, which was up 2123.32% from $224.6 million recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' EBT ranged from a high of $302.2 million in Q2 2024 and a low of $34.9 million during Q4 2021
  • Moreover, its 5-year median value for EBT was $219.2 million (2023), whereas its average is $215.8 million.
  • Its EBT has fluctuated over the past 5 years, first crashed by 5764.56% in 2021, then surged by 38022.92% in 2022.
  • Zimmer Biomet Holdings' EBT (Quarter) stood at $34.9 million in 2021, then skyrocketed by 380.23% to $167.6 million in 2022, then soared by 69.75% to $284.5 million in 2023, then increased by 1.58% to $289.0 million in 2024, then dropped by 3.39% to $279.2 million in 2025.
  • Its EBT stands at $279.2 million for Q3 2025, versus $224.6 million for Q2 2025 and $229.0 million for Q1 2025.